- About Us
- Services & Solutions
- Services by Functionality
- Services by Development Stage
- Proprietary Technologies
- Specialized Expertise
- Quality & Compliance
- Insights & Resources
- News & Events
At MedPharm, we specialize in the development of pharmaceutical products that rely on non-oral, non-invasive, and targeted delivery routes—each with its own scientific and regulatory complexity.
From dermal and transdermal systems to ophthalmic, nasal, mucosal, and parenteral routes, we bring decades of experience, specialized testing platforms, and integrated development support to ensure your therapy reaches its site of action safely, effectively, and consistently.
Our knowledge of formulation behavior, tissue interaction, and local/systemic absorption dynamics enables us to solve delivery challenges that conventional CDMOs aren’t equipped to handle.
Each route of delivery presents unique opportunities—and unique risks. At MedPharm, we help you navigate the science, testing, and strategy needed to unlock the full potential of your drug product.
Explore the diverse delivery pathways we support—each backed by deep formulation science, custom testing models, and global regulatory alignment. MedPharm will help you deliver with precision.
Lorem ipsum dolor sit amet consectetur. Tortor turpis tincidunt platea cursus nullam faucibus. Lacus.
Targeted delivery to the skin for local action (e.g., inflammation, infection, or barrier repair). Expertise in optimizing formulation penetration, retention, and patient experience for creams, gels, ointments, sprays, and foams.
Advancing Formulations for Localized and Systemic GI Therapies
At MedPharm, we specialize in the development of innovative drug products targeting the gastrointestinal (GI) tract, with expertise spanning topical GI treatments to systemic therapies delivered via mucosal absorption. Whether you are formulating for localized conditions or systemic bioavailability through oral mucosal, esophageal, or rectal delivery, our team applies a science-driven approach to maximize therapeutic outcomes.
Formulations for direct absorption through sensitive and highly vascularized mucosa. Includes compatibility testing, retention optimization, and patient-centric dose forms like gels, foams, and suppositories.
Sterile or preservative-containing formulations for ocular delivery. Expertise in particle suspension stability, viscosity control, and packaging compatibility for drops, gels, and sprays.
Specialized formulations for treating outer and middle ear conditions. Focus on retention, comfort, and antimicrobial performance in dose forms like drops, foams, and gels. Custom models support precise efficacy and safety testing.
Fast-acting, non-invasive delivery directly to the lungs through nasal or oral routes, enabling rapid onset, reduced systemic side effects, and effective treatment of both respiratory and systemic conditions. Includes spray formulation design, viscosity tuning, droplet size analysis, and mucosal retention testing.
Niche delivery routes for difficult-to-penetrate tissues. MedPharm offers proprietary nail permeation models and specialized testing platforms for scalp/follicular delivery and keratinized tissue applications.
